Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Astera Labs Inc (NASDAQ: ALAB) closed the day trading at $162.61 up 3.75% from the previous closing price of $156.73. In other words, the price has increased by $3.75 from its previous closing price. On the day, 4.08 million shares were traded. ALAB stock price reached its highest trading level at $164.5 during the session, while it also had its lowest trading level at $155.64.
Ratios:
For a better understanding of ALAB, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 23.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 115.38. For the most recent quarter (mrq), Quick Ratio is recorded 12.27 and its Current Ratio is at 12.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On November 20, 2025, BNP Paribas Exane started tracking the stock assigning a Outperform rating and target price of $225.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’26 when Mazzara Philip sold 10,000 shares for $178.41 per share. The transaction valued at 1,784,071 led to the insider holds 137,040 shares of the business.
PHILIP MAZZARA bought 30,000 shares of ALAB for $4,990,800 on Jan 02 ’26. On Dec 01 ’25, another insider, ALBA MANUEL, who serves as the Director of the company, sold 33,000 shares for $166.18 each. As a result, the insider received 5,483,981 and left with 352,863 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 27465416704 and an Enterprise Value of 26362310656. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 144.77, and their Forward P/E ratio for the next fiscal year is 67.44. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 36.61 while its Price-to-Book (P/B) ratio in mrq is 21.60. Its current Enterprise Value per Revenue stands at 36.46 whereas that against EBITDA is 236.293.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.53, which has changed by 0.278481 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is 1.26%, while the 200-Day Moving Average is calculated to be 18.81%.
Shares Statistics:
Over the past 3-months, ALAB traded about 5.92M shares per day on average, while over the past 10 days, ALAB traded about 4320840 shares per day. A total of 168.90M shares are outstanding, with a floating share count of 134.36M. Insiders hold about 20.46% of the company’s shares, while institutions hold 66.59% stake in the company. Shares short for ALAB as of 1765756800 were 12293014 with a Short Ratio of 2.08, compared to 1763078400 on 10645508. Therefore, it implies a Short% of Shares Outstanding of 12293014 and a Short% of Float of 9.8400004.
Earnings Estimates
A comprehensive evaluation of Astera Labs Inc (ALAB) is underway, with the input of 19.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.52, with high estimates of $0.56 and low estimates of $0.47.
Analysts are recommending an EPS of between $1.8 and $1.76 for the fiscal current year, implying an average EPS of $1.78. EPS for the following year is $2.37, with 19.0 analysts recommending between $2.81 and $2.0.
Revenue Estimates
17 analysts predict $249.46M in revenue. The current quarter. It ranges from a high estimate of $251.3M to a low estimate of $248.9M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $141.1MFor the next quarter, 17 analysts are estimating revenue of $258.71M. There is a high estimate of $266.45M for the next quarter, whereas the lowest estimate is $249.1M.
A total of 21 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $833.3M, while the lowest revenue estimate was $774.54M, resulting in an average revenue estimate of $827.5M. In the same quarter a year ago, actual revenue was $396.29MBased on 19 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.33B and the low estimate is $1.07B.
